angiotensin receptor blocker
Showing 1 - 25 of 9,194
Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)
Not yet recruiting
- Aortic Valve Stenosis
- +5 more
- Valsartan
- Placebo Oral Tablet
-
Limoges, FranceLimoges university hospital
Dec 23, 2022
Acute Kidney Injury Trial (IRBESARTAN, tablet, 150 mg, Placebo, tablet, 150 mg)
Not yet recruiting
- Acute Kidney Injury
- IRBESARTAN, tablet, 150 mg
- Placebo, tablet, 150 mg
- (no location specified)
Aug 8, 2022
COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Candesartan Cilexetil
- +3 more
-
Guntur, India
- +4 more
Mar 13, 2022
Coarctation of Aorta, High Blood Pressure Trial in Rochester (Losartan, Amlodipine, Placebo)
Not yet recruiting
- Coarctation of Aorta
- High Blood Pressure
- Losartan
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 21, 2023
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li,MD
Apr 18, 2023
Heart Failure, Systolic Trial in Karachi (Sacubitril/valsartan)
Completed
- Heart Failure, Systolic
-
Karachi, Sindh, PakistanNational Institute of Cardiovascular Diseases
May 20, 2022
Hypertension Trial in London (Preoperative ACEi/ARB management)
Completed
- Hypertension
- Preoperative ACEi/ARB management
-
London, Ontario, CanadaLondon Health Sciences Centre
Oct 21, 2021
Myocardial Infarction With Non-obstructive Coronary Arteries Trial in Worldwide (Beta blocker, ACEI, ARB)
Recruiting
- Myocardial Infarction With Non-obstructive Coronary Arteries
- Beta blocker
- +2 more
-
Adelaide, Sout Australi, Australia
- +19 more
Sep 6, 2021
Cardiovascular Diseases, Hypertension Trial in San Francisco (Losartan, Placebo)
Recruiting
- Cardiovascular Diseases
- Hypertension
- Losartan
- Placebo
-
San Francisco, CaliforniaSan Francisco Veterans' Affairs Medical Center
Apr 29, 2022
Pulmonary Hypertension Trial in Badalona (Sacubitril / Valsartan Oral Tablet [Entresto])
Completed
- Pulmonary Hypertension
- Sacubitril / Valsartan Oral Tablet [Entresto]
-
Badalona, Barcelona, SpainGermans Trias i Pujol University Hospital
Sep 23, 2021
SARS-CoV-2, COVID-19 Trial in Austria, Germany (ACE inhibitor, angiotensin receptor blocker)
Completed
- SARS-CoV-2
- COVID-19
- ACE inhibitor, angiotensin receptor blocker
-
Innsbruck, Tyrol, Austria
- +30 more
Aug 18, 2022
Heart Failure Trial in Saga (Sacubitril Valsartan Sodium Hydrate, Standard treatment)
Recruiting
- Heart Failure
- Sacubitril Valsartan Sodium Hydrate
- Standard treatment
-
Saga, JapanSaga University Hospital
Dec 27, 2021
Chronic Kidney Disease, Proteinuria, Children Trial in Multiple Locations (Finerenone (Kerendia, BAY94-8862))
Not yet recruiting
- Chronic Kidney Disease
- +2 more
- Finerenone (Kerendia, BAY94-8862)
-
Multiple Locations, Australia
- +22 more
Aug 10, 2022
Idiopathic Membranous Nephropathy Trial in Aarhus (100 mg AP1189, Placebo)
Recruiting
- Idiopathic Membranous Nephropathy
- 100 mg AP1189
- Placebo
-
Aarhus, DenmarkAarhus Universitetshospital
Sep 21, 2021
Hypertension, COVID-19 Trial in Galway (Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor)
Suspended
- Hypertension
- COVID-19
- Thiazide or Thiazide-like diuretics
- +3 more
-
Galway, IrelandUniversity Hospital Galway
Jun 26, 2020
Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in United States (drug, behavioral, other)
Completed
- Cognitively Normal Older Adults
- +3 more
- Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)
- +3 more
-
Kansas City, Kansas
- +3 more
Feb 12, 2022
Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2
Recruiting
- Diabetes Mellitus
- Cardiovascular Diseases
- Renin-angiotensin-aldosterone system inhibitors
- +2 more
-
Singapore, SingaporeSingapore General Hospital (SGH)
Apr 28, 2021
Aortic Stenosis Trial in Québec, Odense (Angiotensin Receptor Blockers, Placebo)
Recruiting
- Aortic Stenosis
- Angiotensin Receptor Blockers
- Placebo
-
Québec, Quebec, Canada
- +1 more
Mar 28, 2022
Coronavirus Disease 2019, COVID-19 Trial in Australia, India (Angiotensin Receptor Blockers, Placebo)
Completed
- Coronavirus Disease 2019
- COVID-19
- Angiotensin Receptor Blockers
- Placebo
-
Camperdown, New South Wales, Australia
- +21 more
Mar 2, 2022
Renin Angiotensin Aldosterone System Genetic Polymorphism on
Recruiting
- Myocardial Infarction
-
Cairo, EgyptAin Shams University
May 16, 2023
Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors
Not yet recruiting
- Aortic Valve Stenosis
- Angiotensin Receptor-Neprilysin Inhibitor
- antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 4, 2023
Novel Antidiabetic Drug Combined With Angiotensin
Recruiting
- Type 2 Diabetes
- Antidiabetic Drugs
-
Beijing, Beijing, China
- +1 more
Jun 20, 2023